{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T12:35:51Z","timestamp":1765456551188,"version":"3.46.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100020050","name":"Japan Intractable Diseases Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["JPMH20FC1039"],"award-info":[{"award-number":["JPMH20FC1039"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.braindev.2025.104394","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T15:03:15Z","timestamp":1752591795000},"page":"104394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characteristics of withdrawal seizures in children with refractory status epilepticus who responded favorably to continuous midazolam therapy"],"prefix":"10.1016","volume":"47","author":[{"given":"Hirokazu","family":"Takeuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenjiro","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikako","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuki","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Koichihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuya","family":"Ueta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-Ichiro","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2025.104394_bb0005","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus--Report of the ILAE task force on classification of status epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2025.104394_bb0010","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1007\/s00415-021-10600-y","article-title":"Occurrence of status epilepticus in persons with epilepsy is determined by sex, epilepsy classification, and etiology: a single center cohort study","volume":"268","author":"Langenbruch","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.braindev.2025.104394_bb0015","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.10286","article-title":"Status epilepticus in a population- based cohort with childhood-onset epilepsy in Finland","volume":"52","author":"Sillanp\u00e4\u00e4","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2025.104394_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.braindev.2025.104394_bb0025","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00415-016-8074-7","article-title":"Midazolam and thiopental for the treatment of refractory status epilepticus: a retrospective comparison of efficacy and safety","volume":"263","author":"Bellante","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/j.braindev.2025.104394_bb0030","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1177\/088307389901400909","article-title":"Efficacy and mortality in treatment of refractory generalized convulsive status epilepticus in children: a meta-analysis","volume":"14","author":"Gilbert","year":"1999","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2025.104394_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.braindev.2024.104306","article-title":"Japanese guidelines for treatment of pediatric status epilepticus \u2013 2023","volume":"47","author":"Kikuchi","year":"2025","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2025.104394_bb0040","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s13312-014-0543-4","article-title":"Consensus guidelines on management of childhood convulsive status epilepticus","volume":"51","author":"Mishra","year":"2014","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.braindev.2025.104394_bb0045","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s00134-005-2579-3","article-title":"Withdrawal following sufentanil\/propofol and sufentanil\/midazolam. Sedation in surgical ICU patients: correlation with central nervous parameters and endogenous opioids","volume":"31","author":"Korak-Leiter","year":"2005","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.braindev.2025.104394_bb0050","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/pan.13591","article-title":"The impact of a quality improvement project to standardize pain, agitation, and withdrawal assessments on the use of morphine and midazolam in the pediatric intensive care unit","volume":"29","author":"Kongkiattikul","year":"2019","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.braindev.2025.104394_bb0055","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1097\/CCM.0b013e318181600d","article-title":"Withdrawal symptoms in critically ill children after long-term administration of sedatives and\/or analgesics: a first evaluation","volume":"8","author":"Ista","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.braindev.2025.104394_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/WNP.0000000000000806","article-title":"American clinical neurophysiology society\u2019s standardized critical care EEG terminology: 2021 version","volume":"38","author":"Hirsch","year":"2021","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.braindev.2025.104394_bb0065","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1528-1157.2002.28501.x","article-title":"Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review","volume":"43","author":"Claassen","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2025.104394_bb0070","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1046\/j.1528-1157.2001.21301.x","article-title":"Outcome of severe refractory status epilepticus in children","volume":"42","author":"Sahin","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2025.104394_bb0075","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/08830738050200060201","article-title":"Status epilepticus: clinical analysis of a treatment protocol based on midazolam and phenytoin","volume":"20","author":"Brevoord","year":"2005","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2025.104394_bb0080","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.seizure.2004.12.005","article-title":"Efficacy of continuous midazolam infusion and mortality in childhood refractory generalized convulsive status epilepticus","volume":"14","author":"Ozdemir","year":"2005","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2025.104394_bb0085","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1007\/s00134-006-0362-8","article-title":"High-dose midazolam therapy for refractory status epilepticus in children","volume":"32","author":"Morrison","year":"2006","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.braindev.2025.104394_bb0090","doi-asserted-by":"crossref","first-page":"e1191","DOI":"10.1212\/WNL.0000000000200818","article-title":"Management of Refractory Status Epilepticus: an international cohort study (MORSE CODe) analysis of patients managed in the ICU","volume":"99","author":"Chiu","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2025.104394_bb0095","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/PCC.0000000000000900","article-title":"Refractory status epilepticus in children: intention to treat with continuous infusions of midazolam and pentobarbital","volume":"17","author":"Tasker","year":"2016","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.braindev.2025.104394_bb0100","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/00003246-199307000-00011","article-title":"Midazolam in the treatment of status epilepticus in children","volume":"21","author":"Rivera","year":"1993","journal-title":"Crit Care Med"},{"key":"10.1016\/j.braindev.2025.104394_bb0105","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/088307380201700203","article-title":"Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus","volume":"17","author":"Singhi","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2025.104394_bb0110","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1177\/08830738020170123002","article-title":"Eight-year study of childhood status epilepticus: midazolam infusion in management and outcome","volume":"17","author":"Koul","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2025.104394_bb0115","first-page":"275","article-title":"Complications during the management of pediatric refractory status epilepticus with benzodiazepine and pentobarbital infusions","volume":"19","author":"Patten","year":"2015","journal-title":"Ind J Crit Care Med"},{"key":"10.1016\/j.braindev.2025.104394_bb0120","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ejpn.2015.05.007","article-title":"Etiology, clinical course and response to the treatment of status epilepticus in children: a 16 year single-center experience based on 602 episodes of status epilepticus","volume":"19","author":"Kravljanac","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.braindev.2025.104394_bb0125","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.pediatrneurol.2007.02.012","article-title":"Efficacy of intravenous midazolam for status epilepticus in childhood","volume":"36","author":"Hayashi","year":"2007","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2025.104394_bb0130","doi-asserted-by":"crossref","DOI":"10.1177\/17562864231214846","article-title":"Risk factors for super-refractory and mortality in generalized convulsive status epilepticus: a 10-year retrospective cohort study","volume":"16","author":"Wang","year":"2023","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.braindev.2025.104394_bb0135","first-page":"e1955","article-title":"Association between induced burst suppression and clinical outcomes in patients with refractory status epilepticus, a 9-year cohort study","volume":"100","author":"Fisch","year":"2023","journal-title":"Fisch U Neurol"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760425000762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760425000762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T12:32:30Z","timestamp":1765456350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760425000762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0387760425000762"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2025.104394","relation":{},"ISSN":["0387-7604"],"issn-type":[{"type":"print","value":"0387-7604"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of withdrawal seizures in children with refractory status epilepticus who responded favorably to continuous midazolam therapy","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2025.104394","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Japanese Society of Child Neurology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104394"}}